Cargando…
By-Passing Large Screening Experiments Using Sequencing as a Tool to Identify scFv Fragments Targeting Atherosclerotic Lesions in a Novel In Vivo Phage Display Selection
Atherosclerosis is a chronic, progressive inflammatory disease that may develop into vulnerable lesions leading to thrombosis. To interrogate the molecular components involved in this process, single-chain variable fragments (scFvs) from a semi-synthetic human antibody library were selected on the l...
Autores principales: | Deramchia, Kamel, Jacobin-Valat, Marie-Josee, Laroche-Traineau, Jeanny, Bonetto, Stephane, Sanchez, Stephane, Dos Santos, Pierre, Massot, Philippe, Franconi, Jean-Michel, Martineau, Pierre, Clofent-Sanchez, Gisele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397503/ https://www.ncbi.nlm.nih.gov/pubmed/22837671 http://dx.doi.org/10.3390/ijms13066902 |
Ejemplares similares
-
An innovative flow cytometry method to screen human scFv-phages selected by in vivo phage-display in an animal model of atherosclerosis
por: Hemadou, Audrey, et al.
Publicado: (2018) -
A Recombinant Human Anti-Platelet scFv Antibody Produced in Pichia pastoris for Atheroma Targeting
por: Vallet-Courbin, Amelie, et al.
Publicado: (2017) -
A Nano-Emulsion Platform Functionalized with a Fully Human scFv-Fc Antibody for Atheroma Targeting: Towards a Theranostic Approach to Atherosclerosis
por: Bonnet, Samuel, et al.
Publicado: (2021) -
Data on atherosclerosis specific antibody conjugation to nanoemulsions
por: Prévot, Geoffrey, et al.
Publicado: (2017) -
In Vivo Human Single‐Chain Fragment Variable Phage Display‐Assisted Identification of Galectin‐3 as a New Biomarker of Atherosclerosis
por: Hemadou, Audrey, et al.
Publicado: (2021)